‘Sweet Dreams’, ‘Happy Days’ and elevated 24-h urine 5-hydroxyindoleacetic acid excretion

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Annals of Clinical Biochemistry

• Publication date

  2013-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1258/acb.2012.012041PMID 23086978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased plasma concentrations of tumour markers in the absence of neoplasia

  2011cited by this paper
• Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.

  2010cited by this paper
• Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin A following over-the-counter 5-hydroxytryptophan intake.

  2008cited by this paper
• The dietary supplement 5-hydroxytryptophan and urinary 5-hydroxyindole acetic acid

  2008cited by this paper
• Chromogranin A: is it a useful marker of neuroendocrine tumors?

  2007cited by this paper
• The flushing patient: differential diagnosis, workup, and treatment.

  2006cited by this paper
• Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours

  2005cited by this paper
• Tryptophan and 5-hydroxytryptophan for depression.

  2001cited by this paper
• Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

  1999cited by this paper
• Carcinoid tumour.

  1998cited by this paper
• 5-Hydroxytryptophan: a clinically-effective serotonin precursor.

  1998cited by this paper
• The incidence of elevations in urine 5-hydroxyindoleacetic acid.

  1998cited by this paper
• Effects of Drugs on Clinical Laboratory Tests

  1997cited by this paper
• The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid.

  1995cited by this paper
• Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors.

  1986cited by this paper
• Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid.

  1985cited by this paper
• Studies with the serotonin precursor, 5-hydroxytryptophan, in experimental animals and man.

  1957cited by this paper
• Increase in tissue serotonin following administration of its precursor 5-hydroxytryptophan.

  1957cited by this paper
• The Carcinoid Tumour

  1949cited by this paper

• A Case of Functional Bowel Disease Misdiagnosed as Carcinoid Syndrome

  2023cites this paper
• Interpretation of Unexpectedly High Levels of Endocrine Tumor Markers.

  2018cites this paper
• Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations

  2017cites this paper
• Development of liquid chromatography mass spectrometric methods for quantification of metabolites from cellular level to clinical biomarkers

  2015cites this paper
• Transient elevation of serum 5-HIAA by dietary serotonin and distribution of 5-HIAA in serum protein fractions

  2014cites this paper
• The Diagnosis of Neuroendocrine Tumours: An Endocrine Perspective

  year unknowncites this paper